Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mundipharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (114)
ARTG (99)
Australian public assessment report (AusPar) (9)
Prescription medicine registration (2)
Cancellation or suspension (1)

Date

2024 (16)
2023 (1)
2022 (62)
2021 (3)
2020 (28)
2019 (5)
2018 (7)
2017 (19)
2016 (11)
2015 (8)
2014 (8)
2013 (14)
2012 (1)
2011 (2)
2010 (7)
2005 (6)
2003 (3)
2001 (3)
2000 (7)
1999 (4)
1996 (1)
1995 (3)
1994 (1)
1993 (3)
1991 (2)

Search

Sponsor content

225 result(s) found, displaying 51 to 60

MS CONTIN SUSPENSION morphine sulfate pentahydrate 100mg modified release granules sachet Cancelled under Section 30(1)(c) of the Act

4 April 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYNORM oxycodone hydrochloride 5mg capsule bottle Cancelled under Section 30(1)(c) of the Act

10 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYNORM oxycodone hydrochloride 10mg capsule bottle Cancelled under Section 30(1)(c) of the Act

10 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
OXYNORM oxycodone hydrochloride 20mg capsule bottle Cancelled under Section 30(1)(c) of the Act

10 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
MS MONO morphine sulfate pentahydrate 30mg modified release capsule bottle Cancelled under Section 30(1)(c) of the Act

9 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
MS MONO morphine sulfate pentahydrate 60mg modified release capsule bottle Cancelled under Section 30(1)(c) of the Act

9 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
MS MONO morphine sulfate pentahydrate 90mg modified release capsule bottle Cancelled under Section 30(1)(c) of the Act

9 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
MS MONO morphine sulfate pentahydrate 120mg modified release capsule bottle Cancelled under Section 30(1)(c) of the Act

9 March 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
BUPRETEC buprenorphine 5 micrograms/hour transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

18 February 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
BUPANNUS buprenorphine 5 micrograms/hour transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

18 February 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.